Comunicado de la FDA sobre la seguridad de los medicamentos: Actualizaci ón del estudio de seguridad sobre Chantix (vareniclina) y el riesgo de sucesos cardiovasculares adversos
El 12 de diciembre, 2012, La Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) le informó al público sobre los resultados de un extenso análisis combinado (denominado metanálisis) de estudios clínicos que compararon a pacientes que recibieron el medicamento para dejar de fumar Chantix (vare niclina) con pacientes que recibieron un placebo (un tratamiento inactivo). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 23, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Varenicline Strongly Recommended for Smoking Cessation
Guideline offers simple practice changes that may increase effectiveness of tobacco - dependence pharmacotherapy (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 23, 2020 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Internal Medicine, Oncology, Pharmacy, Psychiatry, Pulmonology, Journal, Source Type: news

Varenicline Strongly Recommended for Smoking Cessation
THURSDAY, July 23, 2020 -- Varenicline is strongly recommended over the patch for adult smokers hoping to quit, according to an American Thoracic Society practice guideline published online in the July 15 issue of the American Journal of Respiratory... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 23, 2020 Category: Pharmaceuticals Source Type: news

Relapse prevention interventions for smoking cessation
Updated review found that behavioural interventions provided no worthwhile benefit in preventing relapse in assisted abstainers. Moderate certainty evidence suggests that extended treatment with varenicline but not bupropion helped to prevent relapse. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 21, 2020 Category: Consumer Health News Source Type: news

Experts strongly recommend varenicline over the patch for adult smokers hoping to quit
(American Thoracic Society) Smoking cessation initiatives notwithstanding, along with provocative public health campaigns and clinical guidance, quitting tobacco has remained elusive for many smokers. The American Thoracic Society's new clinical practice guideline on treatment for tobacco dependence in adults addresses how clinicians may deal with patients' reluctance to quit, one of a number of issues not previously assessed in the older guidelines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2020 Category: International Medicine & Public Health Source Type: news

Safety of varenicline as an aid to smoking cessation in professional drivers and its impact on driving behaviors: an observational cohort study of taxi drivers in Beijing - Chu S, Liang L, Jing H, Zhang D, Tong Z.
INTRODUCTION: Varenicline is an effective smoking cessation medicine. However, the possible adverse neuropsychiatric events reported by Food and Drug Administration for varenicline may cause safety problems for professional drivers. We aimed to investigate... (Source: SafetyLit)
Source: SafetyLit - June 10, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

UniSA research uncovers treatment combo that sees smokers six times more likely to quit
(University of South Australia) New research led by the University of South Australia has found that smokers who receive the medication varenicline tartrate combined with Quitline counselling following a period of hospitalisation due to a tobacco-related illness are six times more likely to quit smoking than those who attempt to stop without support. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 1, 2020 Category: International Medicine & Public Health Source Type: news

Varenicline Seems Safe for Adults Without Depression
Risk for CV, neuropsychiatric hospitalizations lower for varenicline versus nicotine replacement therapy (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - February 28, 2020 Category: Psychiatry Tags: Cardiology, Family Medicine, Internal Medicine, Neurology, Pharmacy, Psychiatry, Journal, Source Type: news

Varenicline Seems Safe for Adults Without Depression
FRIDAY, Feb. 28, 2020 -- For adults without a recent history of depression, use of varenicline for smoking cessation does not appear to be associated with an increased risk for cardiovascular (CV) or neuropsychiatric hospitalizations when compared... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 28, 2020 Category: Pharmaceuticals Source Type: news

New study supports the safety of varenicline
(Society for the Study of Addiction) A real-world study of over 600,000 adult participants without a history of depression has found that the stop-smoking medication varenicline (marketed as Chantix and Champix) does not appear to be associated with an increased risk of cardiovascular or neuropsychiatric hospitalization compared with nicotine replacement therapy (NRT). These findings confirm those of earlier clinical trials, providing further evidence of the safety of varenicline as an aid to stop smoking. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 20, 2020 Category: International Medicine & Public Health Source Type: news

Podcast: Can people stop smoking by cutting down the amount they smoke first?
There are more than 50 Cochrane Reviews of the effects of interventions to help people quit smoking; one of which investigates whether reducing smoking before quitting might be an alternative to stopping suddenly. It was updated in September 2019 and we asked lead author, Nicola Lindson, from the Cochrane Tobacco Addiction Group based in the University of Oxford in the UK to tell us about their latest findings.The standard way that people are told to quit smoking is to smoke as normal until a quit day, and then stop using all cigarettes. However, this is daunting for many, and those who have tried it without success might ...
Source: Cochrane News and Events - January 2, 2020 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Smoking cessation treatment targets adolescents
This study found that while there was no significant difference between the varenicline group and the placebo group at end of treatment, those in the varenicline group quit earlier in the trial and were less likely to relapse after the trial was over. And it encourages new treatments designs for adolescents. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 10, 2019 Category: International Medicine & Public Health Source Type: news

Featured Review: Can people stop smoking by cutting down the amount they smoke first?
This Cochrane Review looks at whether cutting down before quitting helps people to stop smoking, and the best ways that people can cut down to help them stop completely, the study included 51 studies of over 22,000 people who smoked tobacco.Nicola Lindson, lead author of this Cochrane review explains, “The standard way people are told to quit smoking is to smoke as normal until a quit day, when they stop using all cigarettes. However, many have tried this before and been unsuccessful, and might like to try something new.”“Some people prefer to cut down the number of cigarettes they smoke before quitting completely. H...
Source: Cochrane News and Events - October 3, 2019 Category: Information Technology Authors: Katie Abbotts Source Type: news

varenicline (Chantix)
Title: varenicline (Chantix)Category: MedicationsCreated: 2/28/2008 12:00:00 AMLast Editorial Review: 8/14/2019 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - August 14, 2019 Category: Respiratory Medicine Source Type: news

FDA Drug Safety Communication: Chantix (varenicline) drug label now contains updated efficacy and safety information
[7-22-2011] The U.S. Food and Drug Administration (FDA) has approved an updated drug label for the smoking cessation aid Chantix (varenicline) to include information about the efficacy and safety of the drug in two patient populations who may benefit greatly from giving up smoking �those with cardiovascular disease and those with chronic obstructive pulmonary disease (COPD). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 28, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news